Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
US Physical Therapy ( (USPH) ) just unveiled an update.
On March 6, 2026, U.S. Physical Therapy updated its investor presentation, giving shareholders and analysts an expanded overview of its footprint, financial performance and strategic priorities in outpatient rehabilitation and industrial injury prevention. The materials underscore that the company operates over 780 clinics in 44 states, leverages a proven partner‑based model, and is pursuing scale in a highly fragmented $40‑plus‑billion market where outpatient settings dominate orthopedic rehab care.
The refreshed presentation highlights trailing 12‑month revenue of about $781 million, adjusted EBITDA of $95 million, 16% revenue growth and a $1.80 annual dividend as of year‑end 2025, signaling continued financial momentum. It also details the favorable demand backdrop, noting that musculoskeletal injuries are widespread yet under‑treated with outpatient physical therapy, and positions U.S. Physical Therapy as a consolidator benefiting from demographic trends, shifting care to lower‑cost outpatient providers and a diversified payor base, which may support further clinic expansion and acquisition activity.
The most recent analyst rating on (USPH) stock is a Buy with a $102.00 price target. To see the full list of analyst forecasts on US Physical Therapy stock, see the USPH Stock Forecast page.
Spark’s Take on USPH Stock
According to Spark, TipRanks’ AI Analyst, USPH is a Neutral.
USPH scores as a mid-range opportunity: improving profitability and strong free cash flow, plus upbeat guidance and operational momentum, support the outlook. The score is held back primarily by premium valuation (high P/E) and mixed technicals, alongside the fundamental risk of reimbursement/payer pressures and a recent TTM revenue decline.
To see Spark’s full report on USPH stock, click here.
More about US Physical Therapy
U.S. Physical Therapy, Inc. is a national operator of outpatient physical and occupational therapy clinics and a provider of industrial injury prevention services, with more than 780 owned or managed locations across 44 states. Headquartered in Houston and founded in 1990, the company generates about 85% of its revenue from physical therapy operations and 15% from injury prevention, serving a fragmented U.S. rehabilitation market exceeding $40 billion in size.
The company positions itself as a leading public physical therapy platform with over 7,200 employees and a diversified payor mix, targeting favorable demographic trends such as an aging, active and increasingly obese population. With trailing 12‑month revenue of roughly $781 million, adjusted EBITDA of $95 million and 16% year‑over‑year revenue growth as of December 31, 2025, management emphasizes both organic expansion and acquisitions as key drivers in consolidating a market where no single player holds more than a 10% share.
Average Trading Volume: 207,885
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.23B
For a thorough assessment of USPH stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- Ford Mustang Cobra Jet Fastest Electric Car on the Planet, Ford Stock (NYSE:F) Notches Up
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test

